Gut microbiome composition influences brain function and behavior via neural, endocrine, and immune pathways. Using dominance and submissiveness mouse models, we show microbiome differences drive depressive-like behavior, supporting targeted microbiome modulation as a potential therapeutic strategy for behavioral disorders.